Monday, October 4, 2021

// // Leave a Comment

Why monoclonal antibodies are expensive and hard to make in the fight against COVID-19.

Monoclonal antibody treatments have given new hope for those fighting COVID-19, and they've been intensely politicized as well.

from Google Alert - health https://ift.tt/3l4PqIK
via IFTTT

0 comments:

Post a Comment